Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
The drugmaker raised its full-year sales forecast to $63.4 billion to $64.4 billion on increased demand for key products, particularly
Read More
Merck & Co Inc
Here are JPMorgan’s top drug stock picks into earnings
These are JPMorgan's top drug picks heading into earnings. Source link
Read More
Apple and Microsoft are among the ‘Magnificent Seven’ stocks set to report next week. Here’s what that means
Wall Street could be in for a volatile bout of trading next week if this one was anything to go
Read More
Morgan Stanley names its ‘highest conviction’ stock picks for Europe, giving 4 more than 30% upside
Morgan Stanley says it's time for stock-picking in Europe as earnings season and rate cuts are imminent. Source link
Read More
Pharma ETF that’s gone nowhere for 9 years forming ‘monstrous bullish pattern,’ according to the charts
Frank Cappelleri breaks down the trade on the iShares U.S. Pharmaceuticals ETF. Source link
Read More
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
Nearly 75% of patients who took the cancer vaccine and Keytruda were alive without any signs or symptoms of their
Read More
These steady stocks could help you sleep at night as other parts of market are fraught with risk
CNBC Pro screened for stocks with a demonstrated history of low volatility, as interest rate uncertainty rises. Source link
Read More
Stocks making the biggest moves midday: GameStop, Merck, Carnival, Cintas and more
These are the stocks posting the largest moves in midday trading. Source link
Read More
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
Drugmakers are racing to catch up to Madrigal Pharmaceuticals, which has the first drug for NASH liver disease. Meanwhile, AI
Read More